Interactive Insomnia Lecture Flashcards
sleep is primarily regulated by 2 neural systems
Homeostatic process
- proportion of sleep vs wake
Circadian clock
- timing of sleep/wake cycles
Wake promoters
Acetylcholine
Corticotropin-releasing factor
Dopamine
Histamine
Norepinephrine
Orexin
Substance P
Sleep promoters
Adenosine
y-aminobutyric acid (GABA)
Melatonin
healthy sleep cycle
4 stages of NREM prior to first REM
most adults go through 4-6 cycles of 70-120 min
Insomnia epidemiology
1/3
onset early to middle adulthood
rare in childhood or adolescence
2:1 F:M
40% have concurrent psychiatric disorder
insomnia DSM
A complaint of dissatisfaction of sleep quantity or quality: 1+:
-difficulty falling asleep
-difficulty maintaining sleep
-early-morning awakening w/inability to return to sleep
Causes clinical distress
Occurs at least 3 nights/week and present at least 3 months
Not explained by:
-medical or psychiatric conditions
-substance use
-another sleep-wake disorder
Transient, short term, chronic insomnia
transient: <1 wk
Short term: 1-3 wks
Chronic >3 wks
1st line tx for insomnia
CBT-I
combo with sleep hygeine (insuff for on its own)
2nd line tx for insomnia
other psych/behavioral therapy
combined therapies
consider occult comorbid disorders
combo with sleep hygeine (insuff for on its own)
when to reassess tx
every few weeks until stable then every 6 mo as relapse rate is high
non pharm 1st line tx
stimulus control
sleep hygeine
part of CBT-I
CBT-I components
stimulus control
sleep hygeine
relaxation therapy
sleep consolidation
cognitive behavioral therapy
stimulus control
daily journal
sleep when sleepy
avoid blue light
avoid daytime naps
keep worry time during the day
dont force sleep (if no sleep in 20-30 min leave)
Melatonin
MOA
effectiveness
dosing
AE
notes
MOA: binds to MT receptors
effectiveness: dec latency, inc quality, jet lag
dosing: 1-12
AE: HA, Dizzy, nausea
notes: well tolerated
Valerian
MOA
effectiveness
dosing
AE
notes
MOA: unk, poss inc GABA
effectiveness: dec latency, inc quality
dosing: 300-600
AE: HA, dizzy, GI, hepatotoxicity
notes: limited FDA, mult types